
Quinone-Based Compounds in Drug Discovery
Trends and Applications
- 1st Edition - October 25, 2024
- Imprint: Academic Press
- Editors: Umar Ali Dar, Mohd. Shahnawaz, Khalid Rehman Hakeem
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 2 4 1 2 6 - 0
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 2 4 1 2 5 - 3
Quinone-Based Compounds in Drug Discovery: Trends and Applications provides a comprehensive and up-to-date overview of the latest advances in the field of drug discovery using qui… Read more

Purchase options

Institutional subscription on ScienceDirect
Request a sales quoteQuinone-Based Compounds in Drug Discovery: Trends and Applications provides a comprehensive and up-to-date overview of the latest advances in the field of drug discovery using quinone-based materials. The book covers various aspects of quinone-based materials such as their synthesis, characterization, and applications in drug discovery, consolidating current research. It introduces quinones in the pharmacology context and then describes current developments in drugs for key diseases and conditions. Final chapters deal with the regulatory and commercial framework to take quinone-based drugs to the market.
This book will benefit a wide range of readers, including researchers, scientists, and graduate students in the field of drug discovery. Chemists and biochemists will also benefit from the contents of this book.
- Covers various aspects of quinone-based materials, including their synthesis, characterization, and applications in drug discovery
- Includes specific chapters on antibiotic, neuroprotective, anticancer, antioxidant, and cardio protection through the action of quinones
- Incorporates information on the regulatory, intellectual property, commercialization, and clinical development of quinone-based drugs
- Title of Book
- Cover image
- Title page
- Table of Contents
- Copyright
- Dedication
- Contributors
- About the editors
- Preface
- Acknowledgments
- Chapter 1. Introduction to quinone-based materials in drug discovery
- 1.1 Introduction
- 1.2 Chemical properties of quinones
- 1.3 Natural sources and occurrence of quinones in living organisms
- 1.4 Role of quinones in biological processes and signaling pathways
- 1.5 Quinone-based materials in drug discovery
- 1.5.1 Design considerations for developing quinone-based drugs
- 1.5.1.1 Structure-activity relationship (SAR)
- 1.5.2 Electron-withdrawing or donating groups
- 1.5.3 Linker design
- 1.5.4 Prodrug strategies
- 1.6 Strategies for synthesizing and modifying quinone-based compounds
- 1.7 Pharmacokinetic and toxicological aspects of quinone-based drugs
- 1.8 Quinone-based anticancer agents
- 1.9 Quinones as antimicrobial agents
- 1.9.1 Major mechanisms of action and targets of quinone-based antimicrobial agents
- 1.9.2 Limitations of using quinones as antimicrobial agents
- 1.10 Quinone-based materials in neurodegenerative diseases
- 1.10.1 Challenges and future perspectives in utilizing quinones for neuroprotection
- 1.11 Conclusion and future directions
- Chapter 2. Marine-derived quinones: a potential source for drug discovery
- 2.1 Introduction
- 2.2 Definition of marine-derived quinones
- 2.3 Importance of marine-derived quinones in drug discovery
- 2.3.1 Structural diversity
- 2.3.2 Biologically active compounds
- 2.3.3 Drug targets and mechanisms of action
- 2.3.4 Overcoming drug resistance
- 2.3.5 Biodiversity and untapped potential
- 2.4 Biological sources of marine-derived quinones
- 2.5 Marine invertebrates
- 2.5.1 Sponges (phylum Porifera)
- 2.5.1.1 Avarol
- 2.5.1.2 Spongiaquinone-1
- 2.5.1.3 Halenaquinone
- 2.5.1.4 Nakijiquinones
- 2.5.2 Tunicates (phylum Cordata)
- 2.6 Marine microorganisms
- 2.6.1 Fungi
- 2.6.2 Algae
- 2.6.3 Bacteria
- 2.7 Pharmacological potential of marine-derived quinones
- 2.8 Anticancer activity
- 2.9 Antimicrobial activity
- 2.9.1 Antibacterial activity
- 2.9.2 Antifungal activity
- 2.10 Antiinflammatory activity
- 2.11 Antioxidant activity
- 2.12 Other pharmacological activities
- 2.13 Antiviral
- 2.14 Antiparasitic activity
- 2.15 Neuroprotective activity
- 2.16 Cardiovascular effects
- 2.17 Enzyme inhibition
- 2.18 Challenges and future directions in marine-derived quinone research
- 2.18.1 Challenges in marine-derived quinone research
- 2.18.2 Sample collection and access
- 2.18.3 Compound identification
- 2.18.4 Bioactivity screening
- 2.18.5 Synthesis and supply
- 2.19 Future directions in marine-derived quinone research
- 2.19.1 Ecological significance
- 2.19.2 Drug development
- 2.19.3 Mode of action studies
- 2.19.4 Synergy and combination studies
- 2.19.5 Structure-activity relationship (SAR) studies
- 2.20 Conclusion
- Chapter 3. Naturally occurring and structural analogues of quinones offering new research directions for the discovery of anticancer drugs
- 3.1 Introduction
- 3.2 Benzoquinone (1)
- 3.2.1 Thymoquinone (5)
- 3.2.2 Anticancer activity of TQ
- 3.2.3 Mechanisms of anti-cancer activity
- 3.3 Embelin (8)
- 3.3.1 Activity of embelin against different cancers
- 3.3.2 Mechanisms of anti-cancer activity
- 3.4 Streptonigrin (15)
- 3.5 Mitomycin C (16)
- 3.6 Naphthoquinone (3)
- 3.6.1 Plant-derived naphthoquinones
- 3.6.2 Juglone (17)
- 3.6.3 Lawsone (18)
- 3.6.4 Plumbagin (19)
- 3.6.5 Lapachol (20)
- 3.6.6 Shikonin (21)
- 3.6.7 Menadione (44)
- 3.7 Anthraquinone (4)
- 3.7.1 Emodin (54)
- 3.7.2 Aloe-emodin (55)
- 3.7.3 Rhein (56)
- 3.7.4 Mechanisms of anti-cancer activity
- 3.7.5 Damnacanthal (57)
- 3.7.6 Chrysophanol (58)
- 3.7.7 Daunorubicin (59)
- 3.7.8 Doxorubicin (64)
- 3.8 Future perspective
- 3.8.1 Targeted therapies and personalized medicine
- 3.8.2 Combination therapies
- 3.8.3 Drug delivery systems
- 3.8.4 Resistance mechanisms
- 3.8.5 Clinical trials and regulatory approval
- 3.9 Conclusions
- Chapter 4. Understanding quinone derivatives antibacterial and antimicrobial activities relies on the structural activity relationship
- 4.1 Introduction
- 4.1.1 Benzoquinone (1)
- 4.1.2 Embelin (2)
- 4.1.3 Mechanisms of action
- 4.2 Thymoquinone (3)
- 4.2.1 Mechanisms of action
- 4.3 Dithymoquinone (4)
- 4.3.1 Mechanisms of action
- 4.4 Ubiquinone (5)
- 4.5 Naphthoquinone (6)
- 4.5.1 Structure activity relationships of naphthoquinone and its derivatives
- 4.5.2 Lawsone (7)
- 4.5.3 Juglone (8)
- 4.5.4 Menadione (9)
- 4.5.5 Plumbagin (10)
- 4.5.6 Naphthazarin (11)
- 4.5.7 Shikonin (12)
- 4.6 Anthraquinone (49)
- 4.6.1 Alizarin (50)
- 4.6.2 Chrysophanol (51)
- 4.6.3 Purpurin (52)
- 4.6.4 Emodin (53)
- 4.6.5 Aloe emodin (54)
- 4.6.6 Rhein (55)
- 4.7 Future perspective
- 4.8 Conclusions
- Chapter 5. Quinones as antioxidants
- 5.1 Introduction
- 5.1.1 Basic chemistry of quinones
- 5.1.2 Benzoquinones
- 5.1.3 Naphthoquinones
- 5.1.4 Anthraquinones
- 5.1.5 Polycyclic quinones
- 5.1.6 Hydroquinones
- 5.1.7 Quinones with side chains
- 5.2 Electron transfer properties of quinones
- 5.3 Redox reactions involving quinones
- 5.4 Antioxidant mechanisms of quinones
- 5.4.1 Direct antioxidant activity of quinones
- 5.4.1.1 Quenching of reactive oxygen species (ROS)
- 5.4.2 Scavenging of free radicals
- 5.5 Indirect antioxidant activity of quinones
- 5.5.1 Regeneration of other antioxidants (e.g., vitamin E, ascorbic acid)
- 5.6 Modulation of antioxidant enzyme activity (e.g., catalase, superoxide dismutase)
- 5.7 Sources of quinones with antioxidant properties
- 5.7.1 Natural sources of quinones
- 5.7.1.1 Quinones in plants and their biological functions
- 5.7.2 Quinones in foods and their potential health benefits
- 5.8 Synthetic quinones with antioxidant properties
- 5.8.1 Design and synthesis of quinone-based antioxidants
- 5.9 Structure-activity relationships of synthetic quinones
- 5.10 Biological activities of quinones as antioxidants
- 5.10.1 Protection against oxidative damage
- 5.10.1.1 Quinones as lipid peroxidation inhibitors
- 5.11 Quinones as protein oxidation inhibitors
- 5.12 Potential therapeutic applications of quinones
- 5.12.1 Quinones as anticancer agents
- 5.13 Quinones as neuroprotective agents
- 5.14 Quinones as anti-inflammatory agents
- 5.15 Safety and limitations of quinones as antioxidants
- 5.15.1 Potential toxicity and side effects of quinones
- 5.16 Factors affecting the efficacy of quinones as antioxidants
- 5.17 Dosage considerations and interactions with other drugs
- 5.17.1 Dosage considerations
- 5.17.2 Drug-drug interactions
- 5.18 Conclusion
- 5.19 Prospects plant pathogen and research
- Chapter 6. Quinones in the treatment of cardiovascular diseases
- 6.1 Introduction
- 6.2 Manifestations and indications of cardiovascular disease
- 6.2.1 Chest pain or discomfort (angina)
- 6.2.2 Shortness of breath
- 6.2.3 Fatigue
- 6.2.4 Palpitations
- 6.2.5 Dizziness or lightheadedness
- 6.2.6 Swelling (edema)
- 6.3 Risk factors of cardiovascular disease
- 6.3.1 Modifiable risk factors
- 6.3.1.1 Hypertension
- 6.3.1.2 High cholesterol
- 6.3.1.3 Smoking
- 6.3.1.4 Diabetes
- 6.3.1.5 Obesity
- 6.3.1.6 Physical inactivity
- 6.3.1.7 Unhealthy diet
- 6.3.1.8 Stress
- 6.3.1.9 Alcohol consumption
- 6.3.2 Non-modifiable risk factors
- 6.3.2.1 Gender
- 6.3.2.2 Age
- 6.3.2.3 Family history
- 6.3.3 Other risk factors
- 6.3.3.1 Sleep apnea
- 6.3.3.2 Chronic kidney disease
- 6.3.3.3 Certain medical conditions
- 6.3.3.4 The development of preeclampsia
- 6.3.3.5 Race and ethnicity
- 6.3.3.6 Others
- 6.4 Quinones in the treatment of cardiovascular diseases
- 6.4.1 Aloe-emodin
- 6.4.2 Aloin
- 6.4.3 Chrysophanol
- 6.4.4 Cryptotanshinone
- 6.4.5 Emodin
- 6.4.6 Plumbagin
- 6.4.7 Rhein
- 6.4.8 Shikonin
- 6.4.9 TanshinoneIIA
- 6.4.10 Danthron
- 6.4.11 Embelin
- 6.4.12 Purpurin
- 6.5 Molecular docking
- 6.6 Challenges and limitations in using quinones for CVD
- 6.7 Future directions and potential developments
- 6.8 Conclusion
- Abbreviation
- Chapter 7. Quinones: A promising remedy for respiratory health
- 7.1 Introduction
- 7.2 Quinones for the management of respiratory diseases and enhancement of respiratory health
- 7.2.1 Quinones in the management of COPD; (chronic obstructive pulmonary diseases)
- 7.3 Quinones in the management of asthma
- 7.3.1 Quinones in the management of pneumoconiosis
- 7.3.2 Quinones in the management of interstitial lung diseases
- 7.3.3 Quinones in the management of lung cancer
- 7.3.4 Quinones in the management of bacteria and virus-induced respiratory disorders
- 7.3.5 Quinones in the management of fungal-induced respiratory disorders
- 7.4 Conclusion
- Chapter 8. Quinone-based materials in immunotherapy
- 8.1 Introduction
- 8.2 Synthesis and structural aspects of quinone-based materials
- 8.2.1 Design and development of quinone-derived immunotherapeutic agents
- 8.2.2 Rational design strategies
- 8.2.2.1 Functional group modification
- 8.2.3 Synthetic routes and methodologies in quinone-based material synthesis for immunotherapy
- 8.2.3.1 Oxidative coupling
- 8.2.3.2 Electrochemical synthesis
- 8.2.3.3 Catalytic methodologies
- 8.2.3.4 Biomimetic approaches
- 8.2.4 Interaction of quinone materials with immune cells in immunotherapy
- 8.2.4.1 Mechanisms of interaction
- 8.2.4.2 Immunomodulatory effects of quinone-derived compounds
- 8.2.5 Cellular interactions and immunomodulation
- 8.2.5.1 Macrophage polarization
- 8.2.5.2 T cell activation and differentiation
- 8.2.6 Formulation and delivery strategies for quinone-based immunotherapeutic agents
- 8.2.6.1 Nanotechnology in immunotherapy
- 8.2.6.2 Liposomal delivery systems in immunotherapy
- 8.2.6.3 Polymeric nanoparticles in immunotherapy
- 8.2.7 Formulation optimization for improved bioavailability and stability
- 8.2.7.1 Enhanced solubility and stability in quinone compounds
- 8.2.7.2 Cyclodextrin complexation
- 8.2.7.3 Co-delivery systems in immunotherapy
- 8.2.7.4 Co-encapsulation in nanoparticles
- 8.2.7.5 Enhanced therapeutic outcomes
- 8.3 Antibacterial and antifungal effects of quinone-based materials
- 8.3.1 Role of quinones in chemotherapy and antimicrobial agents
- 8.3.2 Use of quinone-containing chemicals in disease prevention and treatment
- 8.3.2.1 Free radical processes (FRP) and their implications
- 8.3.3 Research on quinones and azoles in radiation metabolite generation
- 8.3.4 Role of quinoid structures in radiation chemistry and therapeutic applications
- 8.3.5 Quinone-based antibiotics in battling bacterial infections
- 8.3.6 Addressing bacterial proliferation and biofilm infections
- 8.3.7 Quinone-driven antibiotics: Unveiling potent biocidal attributes
- 8.3.8 Quinone-based antibiotics: Unveiling antibiofilm potency
- 8.4 Antitumoral and anticancer effects of quinone-based materials
- 8.5 Quinone-based materials as radiosensitizers
- 8.6 Regulating the tumor microenvironment with quinone-based materials
- 8.6.1 Quinone-based materials in cancer treatment
- 8.6.1.1 Mechanisms of action
- 8.6.2 Clinical applications
- 8.6.2.1 Enhancing chemotherapy efficacy
- 8.6.2.2 Overcoming drug resistance
- 8.6.2.3 Immune response
- 8.7 Challenges and opportunities in the development of quinone-based materials for immunotherapy
- 8.7.1 Challenges
- 8.7.1.1 Toxicity
- 8.7.1.2 Stability
- 8.7.1.3 Off-target effects
- 8.7.2 Opportunities
- 8.7.2.1 Redox cycling
- 8.7.2.2 Immune response
- 8.7.2.3 Responsive tumor treatments
- 8.7.2.4 Diverse biological activities
- 8.8 Conclusion
- Chapter 9. Quinones as antiinflammatory agents
- 9.1 Introduction
- 9.2 Benzoquinones
- 9.2.1 Embelin
- 9.2.2 Thymoquinone
- 9.2.3 Z-ligustilide
- 9.2.4 Flexibilisquinone
- 9.2.5 Belamcandaquinone A
- 9.2.6 2-octaprenyl-1,4-benzoquinone
- 9.3 Naphthoquinones
- 9.3.1 Lawsone
- 9.3.2 Juglone
- 9.3.3 Shikonin
- 9.3.4 Acetylshikonin
- 9.3.5 Plumbagin
- 9.3.6 Menadione
- 9.3.7 Diosquinone
- 9.3.8 β-lapachone
- 9.4 Anthraquinones
- 9.4.1 Emodin
- 9.4.2 Chrysophanol
- 9.4.3 Physcion
- 9.4.4 Rhein
- 9.4.5 Damnacanthal
- 9.4.6 Rubiadin
- 9.4.7 Purpurin
- 9.5 Other antiinflammatory compounds with quinone motif
- 9.5.1 Pyrroloquinoline quinone
- 9.5.2 Sesquiterpene quinones/quinols
- 9.6 Conclusion
- Chapter 10. Quinones as potential therapeutic agents for metabolic disorders
- 10.1 Introduction
- 10.2 Quinones: A diverse class of compounds
- 10.3 Biological functions and significance
- 10.4 Industrial applications
- 10.4.1 Dye and pigment industry
- 10.4.2 Medicine and pharmaceuticals
- 10.4.3 Energy storage
- 10.5 Chemical synthesis
- 10.6 Metabolic disorders: An overview
- 10.6.1 Metabolic disorders and their impact on health
- 10.6.1.1 Impact on health
- 10.7 Diagnosis and management
- 10.8 The need for effective therapeutic approaches to treat metabolic disorders: Contrasting the potential of quinones
- 10.8.1 The potential of quinones as therapeutics
- 10.9 Challenges and considerations
- 10.10 Quinones: Properties and classification
- 10.10.1 The chemical structure of quinones: A comprehensive exploration
- 10.10.2 Variations in Quinone structure
- 10.10.3 The role of quinones in various biological processes
- 10.11 Applications of quinones
- 10.11.1 Exploring the diversity of quinones: A comprehensive analysis of different types
- 10.11.2 Vitamin K and Naphthoquinone derivatives
- 10.12 The multifaceted role of quinones in biological processes
- 10.12.1 Electron transfer and energy production: Illuminating the powerhouses of cells
- 10.12.2 Redox regulation and antioxidant defense: Preserving cellular equilibrium
- 10.12.3 Enzymatic reactions and metabolism: The molecular architects of biochemical pathways
- 10.12.4 Cellular signaling and communication: Orchestrating Harmonious dialogues
- 10.12.5 Pigmentation and coloration: Painting nature's canvas
- 10.12.6 Defense mechanisms: Chemical guardians of organisms
- 10.12.7 Biomedical applications: Paving the path to health and wellness
- 10.12.7.1 Harnessing quinones to combat oxidative stress in metabolic disorders
- 10.12.7.2 Unraveling the role of quinones in lipid metabolism and regulation: A comprehensive analysis
- 10.12.7.3 Antiinflammatory
- 10.13 Future directions and therapeutic potential
- 10.13.1 Clinical trails
- 10.13.2 Challenge address
- 10.14 Conclusion
- Chapter 11. Quinones as photosensitizers for photodynamic therapy
- 11.1 Introduction
- 11.2 Reactive oxygen species
- 11.2.1 Singlet oxygen
- 11.2.1.1 Biological significance of singlet oxygen
- 11.2.2 Superoxide anion radical
- 11.2.3 Hydroxyl radical
- 11.3 Photosensitizer (PS)
- 11.4 Photodynamic therapy
- 11.5 PDT of quinone
- 11.5.1 Influence of different substituents on the generation of ROS
- 11.5.2 Perylquinone sensitizers: Hypocrellins and hypericin
- 11.6 Redox cycling of quinone
- 11.6.1 Enzymatic reduction of quinones and its cytotoxicity
- 11.7 Effect of electron donor on ROS generation
- 11.8 Biochemistry of ROS
- 11.9 Photocleavage of DNA
- 11.10 Detection of ROS
- 11.10.1 Optical methods
- 11.10.1.1 Detection of superoxide anion (O2•−)
- 11.10.1.2 Detection of hydroxyl radical
- 11.10.1.3 Detection of 1O2
- 11.10.2 EPR method
- 11.10.2.1 Detecting superoxide anion through the spin trapping method
- 11.10.2.2 1O2 detection by EPR-TEMPL method
- 11.11 Conclusion
- Chapter 12. Quinones as redox-active materials for energy applications
- 12.1 Introduction
- 12.2 Related works
- 12.3 Characterization of quinones
- 12.3.1 Electrical and optical properties
- 12.3.2 Properties of quinones
- 12.3.3 Exposure route and pathways
- 12.3.4 Battery energy consumption
- 12.3.5 Energy storage mechanism in quinones
- 12.4 Research findings
- 12.5 Discussion
- 12.6 Conclusion
- Chapter 13. Synthetic strategies for the preparation of quinone-based materials
- 13.1 Introduction
- 13.1.1 Background of interest
- 13.2 Major synthetic strategies of quinone materials
- 13.2.1 Diels–Alder cycloaddition reaction
- 13.2.2 Coupling of the aldehydes with lithiated hydroquinone ethers
- 13.2.3 Radical decarboxylation and quinone addition reaction
- 13.2.4 Grignard reagent conjugated addition to α,β-unsaturated carbonyl group
- 13.2.5 Reductive alkylation of enones
- 13.2.6 Cross-coupling reaction
- 13.2.7 Furylation of quinones
- 13.2.8 Furan polyene cationic cyclization
- 13.3 Other strategies for the synthesis of quinone materials
- 13.3.1 Biosynthetic technologies
- 13.3.2 Primmorph culture
- 13.4 Conclusion
- Chapter 14. Analytical techniques for the characterization of quinone-based materials
- 14.1 Introduction
- 14.2 Applications of characterization and analysis techniques for quinone-based materials
- 14.3 Characterizations and analysis of quinone-based materials
- 14.3.1 UV–Vis characterization of quinone
- 14.3.2 FTIR characterization of quinone
- 14.3.3 HPLC characterization of quinone
- 14.3.4 Electrochemical analysis of quinone-based materials
- 14.4 Conclusion
- Chapter 15. Synthesis, application and regulatory consideration for the development of quinone-based drugs
- 15.1 Introduction
- 15.2 Diverse applications
- 15.3 Natural and synthetic sources
- 15.4 Regulatory considerations
- 15.5 The international regulation
- 15.6 Patent and intellectual property protection of quinone based drugs
- 15.7 Conclusion
- Chapter 16. Intellectual property considerations for quinone-based materials
- 16.1 Introduction
- 16.2 Importance and applications of quinone-based materials
- 16.2.1 Biomedicine
- 16.2.2 Sensors
- 16.2.3 Catalysis
- 16.2.4 Energy storage
- 16.2.5 Electronics
- 16.3 Understanding intellectual property (IP)
- 16.3.1 Definition and types of IP
- 16.3.1.1 Patents
- 16.3.1.2 Trademarks
- 16.3.1.3 Copyrights
- 16.3.1.4 Trade secrets
- 16.3.1.5 Plant varieties
- 16.3.1.6 Industrial designs
- 16.4 Importance of IP in scientific research and material development
- 16.4.1 Encouraging investment
- 16.4.2 Enabling commercialization
- 16.4.3 Promoting knowledge sharing
- 16.4.4 Incentivizing innovation
- 16.4.5 Protecting investments
- 16.4.6 Facilitating collaboration
- 16.4.7 Driving economic growth
- 16.5 Overview of patents in material science
- 16.6 Importance of patents in material science
- 16.6.1 Process of obtaining a patent
- 16.7 Review of existing patents on quinone-based materials
- 16.8 Analysis of successful patent applications
- 16.9 Conclusions
- Chapter 17. Commercialization of quinone-based drugs
- 17.1 Introduction
- 17.2 Antibacterial effects of quinones
- 17.3 Drug effects of quinones and commercialization
- 17.3.1 Anthracyclines
- 17.3.2 Mitomycin C
- 17.3.3 Mitoxantrone
- 17.3.4 Aziridinyl benzoquinones
- 17.3.5 Streptonigrin
- 17.3.6 Lapachols
- 17.3.7 Actinomycin D
- 17.4 Conclusion
- Chapter 18. Clinical development of quinone-based drugs
- 18.1 Introduction
- 18.2 Quinones
- 18.3 Quinone-based molecular electrochemistry and their contributions to medicinal chemistry
- 18.4 Quinones and their importance in drugs
- 18.5 The effects of quinones and clinical studies
- 18.6 Conclusion
- Index
- Edition: 1
- Published: October 25, 2024
- Imprint: Academic Press
- No. of pages: 400
- Language: English
- Paperback ISBN: 9780443241260
- eBook ISBN: 9780443241253
UD
Umar Ali Dar
MS
Mohd. Shahnawaz
KH